Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 326

1.

Detection of the Human Anti-ActRII Antibody Bimagrumab in Serum by Means of Affinity Purification, Tryptic Digestion, and LC-HRMS.

Walpurgis K, Thomas A, Dellanna F, Schänzer W, Thevis M.

Proteomics Clin Appl. 2017 Dec 11. doi: 10.1002/prca.201700120. [Epub ahead of print]

PMID:
29226558
2.

Characterization of in vitro generated metabolites of selected peptides <2 kDa prohibited in sports.

Thomas A, Knoop A, Schänzer W, Thevis M.

Drug Test Anal. 2017 Nov;9(11-12):1799-1803. doi: 10.1002/dta.2306. Epub 2017 Nov 13.

PMID:
28941172
3.

Potential of GHB phase-II-metabolites to complement current approaches in GHB post administration detection.

Piper T, Mehling LM, Spottke A, Heidbreder A, Young P, Madea B, Hess C, Schänzer W, Thevis M.

Forensic Sci Int. 2017 Oct;279:157-164. doi: 10.1016/j.forsciint.2017.08.023. Epub 2017 Aug 26.

PMID:
28869822
4.

Epiandrosterone sulfate prolongs the detectability of testosterone, 4-androstenedione, and dihydrotestosterone misuse by means of carbon isotope ratio mass spectrometry.

Piper T, Putz M, Schänzer W, Pop V, McLeod MD, Uduwela DR, Stevenson BJ, Thevis M.

Drug Test Anal. 2017 Nov;9(11-12):1695-1703. doi: 10.1002/dta.2291. Epub 2017 Oct 27.

PMID:
28836353
5.

Nutrition Status of Young Elite Female German Football Players.

Braun H, von Andrian-Werburg J, Schänzer W, Thevis M.

Pediatr Exerc Sci. 2017 Oct 20:1-11. doi: 10.1123/pes.2017-0072. [Epub ahead of print]

PMID:
28787242
6.

Immunoaffinity techniques coupled to mass spectrometry for the analysis of human peptide hormones: advances and applications.

Thomas A, Schänzer W, Thevis M.

Expert Rev Proteomics. 2017 Sep;14(9):799-807. doi: 10.1080/14789450.2017.1362338. Epub 2017 Aug 4.

PMID:
28758805
7.

Determination of LongR3-IGF-I, R3-IGF-I, Des1-3 IGF-I and their metabolites in human plasma samples by means of LC-MS.

Thomas A, Walpurgis K, Delahaut P, Fichant E, Schänzer W, Thevis M.

Growth Horm IGF Res. 2017 Aug;35:33-39. doi: 10.1016/j.ghir.2017.06.002. Epub 2017 Jun 27.

PMID:
28668757
8.

Expanding analytical options in sports drug testing: Mass spectrometric detection of prohibited substances in exhaled breath.

Thevis M, Krug O, Geyer H, Schänzer W.

Rapid Commun Mass Spectrom. 2017 Aug 15;31(15):1290-1296. doi: 10.1002/rcm.7903.

9.

Do we excrete what we eat? Analysis of stable nitrogen isotope ratios of human urinary urea.

Hülsemann F, Koehler K, Flenker U, Schänzer W.

Rapid Commun Mass Spectrom. 2017 Jul 30;31(14):1221-1227. doi: 10.1002/rcm.7891.

PMID:
28466567
10.

Mass spectrometric characterization of the selective androgen receptor modulator (SARM) YK-11 for doping control purposes.

Thevis M, Piper T, Dib J, Lagojda A, Kühne D, Packschies L, Geyer H, Schänzer W.

Rapid Commun Mass Spectrom. 2017 Jul 30;31(14):1175-1183. doi: 10.1002/rcm.7886.

PMID:
28440570
11.

lmplementation of the prolyl hydroxylase inhibitor Roxadustat (FG-4592) and its main metabolites into routine doping controls.

Eichner D, Van Wagoner RM, Brenner M, Chou J, Leigh S, Wright LR, Flippin LA, Martinelli M, Krug O, Schänzer W, Thevis M.

Drug Test Anal. 2017 Nov;9(11-12):1768-1778. doi: 10.1002/dta.2202. Epub 2017 May 31.

PMID:
28378453
12.

Prediction of human dietary δ15N intake from standardised food records: validity and precision of single meal and 24-h diet data.

Hülsemann F, Koehler K, Wittsiepe J, Wilhelm M, Hilbig A, Kersting M, Braun H, Flenker U, Schänzer W.

Isotopes Environ Health Stud. 2017 Aug;53(4):356-367. doi: 10.1080/10256016.2017.1302447. Epub 2017 Mar 15.

PMID:
28292192
13.

The atypical excretion profile of meldonium: Comparison of urinary detection windows after single- and multiple-dose application in healthy volunteers.

Görgens C, Guddat S, Bosse C, Geyer H, Pop V, Schänzer W, Thevis M.

J Pharm Biomed Anal. 2017 May 10;138:175-179. doi: 10.1016/j.jpba.2017.02.011. Epub 2017 Feb 6.

PMID:
28213178
14.

Detection of SARMs in doping control analysis.

Thevis M, Schänzer W.

Mol Cell Endocrinol. 2017 Jan 27. pii: S0303-7207(17)30053-9. doi: 10.1016/j.mce.2017.01.040. [Epub ahead of print]

PMID:
28137616
15.

Pharmacokinetics and in vitro efficacy of salicylic acid after oral administration of acetylsalicylic acid in horses.

Buntenkötter K, Osmers M, Schenk I, Schänzer W, Machnik M, Düe M, Kietzmann M.

BMC Vet Res. 2017 Jan 19;13(1):28. doi: 10.1186/s12917-017-0955-1.

16.

Creatine and creatine forms intended for sports nutrition.

Andres S, Ziegenhagen R, Trefflich I, Pevny S, Schultrich K, Braun H, Schänzer W, Hirsch-Ernst KI, Schäfer B, Lampen A.

Mol Nutr Food Res. 2017 Jun;61(6). doi: 10.1002/mnfr.201600772. Epub 2017 Mar 30. Review.

PMID:
28019093
17.

Annual banned-substance review: analytical approaches in human sports drug testing.

Thevis M, Kuuranne T, Geyer H, Schänzer W.

Drug Test Anal. 2017 Jan;9(1):6-29. doi: 10.1002/dta.2139. Review.

PMID:
27885819
18.

Simplifying and expanding analytical capabilities for various classes of doping agents by means of direct urine injection high performance liquid chromatography high resolution/high accuracy mass spectrometry.

Görgens C, Guddat S, Thomas A, Wachsmuth P, Orlovius AK, Sigmund G, Thevis M, Schänzer W.

J Pharm Biomed Anal. 2016 Nov 30;131:482-496. doi: 10.1016/j.jpba.2016.09.015. Epub 2016 Sep 15.

PMID:
27693991
19.

Control of methylxanthines in the competition horse: pharmacokinetic/pharmacodynamic studies on caffeine, theobromine and theophylline for the assessment of irrelevant concentrations.

Machnik M, Kaiser S, Koppe S, Kietzmann M, Schenk I, Düe M, Thevis M, Schänzer W, Toutain PL.

Drug Test Anal. 2017 Sep;9(9):1372-1384. doi: 10.1002/dta.2097. Epub 2016 Nov 4.

PMID:
27662634
20.

Genotype-dependent metabolism of exogenous testosterone - new biomarkers result in prolonged detectability.

Piper T, Schänzer W, Thevis M.

Drug Test Anal. 2016 Nov;8(11-12):1163-1173. doi: 10.1002/dta.2095. Epub 2016 Oct 13.

PMID:
27649524

Supplemental Content

Loading ...
Support Center